180 related articles for article (PubMed ID: 3332162)
41. Removal of T cells from bone marrow for transplantation. Comparison of rat monoclonal anti-lymphocyte antibodies of different isotypes.
Hale G; Hoang T; Prospero T; Watt SM; Waldmann H
Mol Biol Med; 1983 Oct; 1(3):305-19. PubMed ID: 6390085
[TBL] [Abstract][Full Text] [Related]
42. [Granulocytic progenitors in bone marrow autografts].
Maraninchi D; Sebahoun G; Chauvet M; Gastaut JA; Novakovitch G; Kulling G; de Chesse R; Forgues L; Mascret B; Carcassonne Y
Nouv Rev Fr Hematol (1978); 1983; 25(4):235-9. PubMed ID: 6353372
[TBL] [Abstract][Full Text] [Related]
43. Autologous bone marrow transplantation for myeloma patients using PNA- and CD19-purged marrow rescue.
Rhodes EG; Baker PK; Rhodes JM; Davies JM; Duguid JK
Bone Marrow Transplant; 1994 Jun; 13(6):795-9. PubMed ID: 7522727
[TBL] [Abstract][Full Text] [Related]
44. Monoclonal antibodies and magnetic microspheres used for the depletion of malignant cells from bone marrow.
Kemshead JT; Treleaven JG; Gibson FM; Ugelstad J; Rembaum A; Philip T
Prog Clin Biol Res; 1985; 175():413-23. PubMed ID: 3991740
[No Abstract] [Full Text] [Related]
45. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
Kasow KA; Sims-Poston L; Eldridge P; Hale GA
Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
[TBL] [Abstract][Full Text] [Related]
46. [Autologous bone marrow transplantation--a new approach in the treatment of neoplastic hematologic diseases. I. Scientific principles and methodology of the treatment].
Nemet D
Lijec Vjesn; 1989 Dec; 111(12):466-74. PubMed ID: 2699909
[TBL] [Abstract][Full Text] [Related]
47. Autologous bone marrow transplantation with marrow decontaminated by immunotoxin T 101 in the treatment of leukemia and lymphoma: first clinical observations.
Gorin NC; Douay L; Laporte JP; Lopez M; Zittoun R; Rio B; David R; Stachowiak J; Jansen J; Cazellas P
Cancer Treat Rep; 1985 Sep; 69(9):953-9. PubMed ID: 3896482
[TBL] [Abstract][Full Text] [Related]
48. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
Sao H; Kitaori K; Kasai M; Shimokawa T; Kato C; Yamanishi H; Ueda R; Morishima Y
Int J Hematol; 1999 Jan; 69(1):27-35. PubMed ID: 10641440
[TBL] [Abstract][Full Text] [Related]
49. CD5 antigen-positive B lymphocytes in human B cell ontogeny during fetal development and after autologous bone marrow transplantation.
Waddick KG; Uckun FM
Exp Hematol; 1993 Jun; 21(6):791-8. PubMed ID: 7684704
[TBL] [Abstract][Full Text] [Related]
50. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S
Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929
[TBL] [Abstract][Full Text] [Related]
51. High efficiency of a new immunological magnetic cell sorting method for T cell depletion of human bone marrow.
Kögler G; Capdeville AB; Hauch M; Brüster HT; Göbel U; Wernet P; Burdach S
Bone Marrow Transplant; 1990 Sep; 6(3):163-8. PubMed ID: 2252955
[TBL] [Abstract][Full Text] [Related]
52. Immunopharmacologic purging of breast cancer from bone marrow for autologous bone marrow transplantation.
Shpall EJ; Anderson IC; Bast RC; Joines WT; Jones RB; Ross M; Edwards S; Eggleston S; Johnston C; Tepperberg M
Prog Clin Biol Res; 1990; 333():321-35; discussion 336. PubMed ID: 2308989
[No Abstract] [Full Text] [Related]
53. Human long-term bone marrow culture as a prognostic factor for hematopoietic reconstitution in autologous transplantation.
Gilabert R; Ayats R
Bone Marrow Transplant; 1994 May; 13(5):635-40. PubMed ID: 8054917
[TBL] [Abstract][Full Text] [Related]
54. The blood bank as a source of hematopoietic stem cells.
Lasky LC
Prog Clin Biol Res; 1986; 211():199-225. PubMed ID: 3515360
[No Abstract] [Full Text] [Related]
55. Immunomagnetic removal of L1210V leukemic cells from mouse bone marrow ex vivo.
Wiedłocha A; Paprocka M; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1991; 39(3):235-41. PubMed ID: 1810216
[TBL] [Abstract][Full Text] [Related]
56. Elevated plasma prostaglandin E2 levels found in 14 patients undergoing autologous bone marrow or stem cell transplantation.
Cayeux SJ; Beverley PC; Schulz R; Dörken B
Bone Marrow Transplant; 1993 Dec; 12(6):603-8. PubMed ID: 7907905
[TBL] [Abstract][Full Text] [Related]
57. Perspectives of monoclonal antibodies in the acute leukaemias.
Hervé P; Wijdenes J; Racadot E
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():198-201. PubMed ID: 2653503
[No Abstract] [Full Text] [Related]
58. Depletion of T cells from human bone marrow with monoclonal antibody CT-2 and complement.
Trigg ME; Billing R; Sondel PM; Dickerman JD; Erickson C; Finlay JL; Bozdech M; Hong R; Padilla-Nash H; Terasaki P
J Biol Response Mod; 1984 Aug; 3(4):406-12. PubMed ID: 6384432
[TBL] [Abstract][Full Text] [Related]
59. Long-term culture of autologous transplanted bone marrow for acute myeloid leukaemia: evidence for an in vitro haemopoietic defect and lack of correlation with the speed of engraftment.
Straetmans N; Ma DD; Herman P; Zenebergh A; Chang A; Deneys V; De Bruyère M; Ferrant A
Bone Marrow Transplant; 1995 Mar; 15(3):421-8. PubMed ID: 7599567
[TBL] [Abstract][Full Text] [Related]
60. The in vitro detection of anti-leukaemia-specific cytotoxicity after autologous bone marrow transplantation for acute leukaemia.
Lowdell MW; Ray N; Craston R; Corbett T; Deane M; Prentice HG
Bone Marrow Transplant; 1997 May; 19(9):891-7. PubMed ID: 9156262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
